Endurant Capital Management’s Boston Scientific BSX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-39,108	Closed	-$2.26M	–	5
2023 Q4	$2.26M	Sell	39,108 -8,785	-18%	-$469K	12.96%	1
2023 Q3	$2.53M	Sell	47,893 -13,098	-21%	-$687K	2.27%	15
2023 Q2	$3.3M	Buy	+60,991	New	+$3.19M	2.88%	12
2022 Q3	–	Sell	-418,165	Closed	-$15.6M	–	53
2022 Q2	$15.6M	Buy	+418,165	New	+$17M	5.47%	3
2021 Q2	–	Sell	-158,702	Closed	-$6.13M	–	65
2021 Q1	$6.13M	Buy	+158,702	New	+$6.01M	1.6%	26
2020 Q3	–	Sell	-106,338	Closed	-$3.73M	–	62
2020 Q2	$3.73M	Buy	+106,338	New	+$3.83M	0.2%	28
2019 Q1	–	Sell	-30,560	Closed	-$1.08M	–	73
2018 Q4	$1.08M	Sell	30,560 -39,847	-57%	-$1.45M	0.57%	36
2018 Q3	$2.71M	Sell	70,407 -2,434	-3%	-$85K	1.21%	28
2018 Q2	$2.38M	Sell	72,841 -314,857	-81%	-$9.5M	1.03%	27
2018 Q1	$10.6M	Buy	387,698 +45,100	+13%	+$1.23M	3.96%	6
2017 Q4	$8.49M	Buy	342,598 +132,100	+63%	+$3.64M	2.6%	13
2017 Q3	$6.14M	Buy	210,498 +82,800	+65%	+$2.29M	1.86%	19
2017 Q2	$3.54M	Sell	127,698 -98,500	-44%	-$2.61M	1%	32
2017 Q1	$5.63M	Sell	226,198 -106,000	-32%	-$2.58M	1.81%	21
2016 Q4	$7.18M	Buy	332,198 +73,900	+29%	+$1.61M	2.97%	9
2016 Q3	$6.15M	Sell	258,298 -108,700	-30%	-$2.59M	2.28%	14
2016 Q2	$8.58M	Sell	366,998 -159,700	-30%	-$3.45M	2.87%	11
2016 Q1	$9.91M	Buy	526,698 +250,600	+91%	+$4.4M	3.21%	6
2015 Q4	$5.09M	Buy	276,098 +21,398	+8%	+$383K	1.7%	21
2015 Q3	$4.18M	Buy	254,700 +109,600	+76%	+$1.87M	1.4%	25
2015 Q2	$2.57M	Sell	145,100 -98,100	-40%	-$1.75M	0.76%	41
2015 Q1	$4.32M	Buy	243,200 +29,900	+14%	+$473K	1.43%	22
2014 Q4	$2.83M	Buy	+213,300	New	+$2.73M	1.11%	29